Equimoxin, 18,92mg/g, Oral gel
Equimoxin, 18,92mg/g, Oral gel
Authorised
- Moxidectin
Product identification
Medicine name:
Equimoxin, 18,92mg/g, Oral gel
Active substance:
- Moxidectin
Target species:
-
Horse
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Moxidectin18.92/milligram(s)1.00gram(s)
Pharmaceutical form:
-
Oral gel
Withdrawal period by route of administration:
-
Oral use
-
Horse
-
Meat and offalno withdrawal periodThe horse must be declared as not intended for human consumption in the horse passport.,
-
Milkno withdrawal periodThe horse must be declared as not intended for human consumption in the horse passport.,
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP54AB02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Lithuania
Package description:
- Plastic Applicator 1 x 14.8 gram(s)
- Plastic Applicator 10 x 14.8 gram(s)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
- Bioveta a.s.
Responsible authority:
- State Food And Veterinary Service
Authorisation number:
- LT/2/22/2711/001-002
Date of authorisation status change:
Reference member state:
-
Czechia
Procedure number:
- CZ/V/0169/001
Concerned member states:
-
Bulgaria
-
Estonia
-
Lithuania
-
Poland
-
Romania
-
Slovakia
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Lithuanian (PDF)
Published on: 12/01/2026
